The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma: a rapid and systematic review

Health Technol Assess. 2001;5(13):1-73. doi: 10.3310/hta5130.
No abstract available

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / economics
  • Brain Neoplasms / pathology
  • Cost-Benefit Analysis*
  • Dacarbazine / analogs & derivatives*
  • Dacarbazine / economics
  • Dacarbazine / therapeutic use*
  • Evidence-Based Medicine
  • Glioma / drug therapy*
  • Glioma / economics
  • Glioma / pathology
  • Humans
  • Recurrence
  • Temozolomide
  • Treatment Outcome*
  • United Kingdom

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Temozolomide